Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Conditions
Interventions
Intervention1: Group D: Group D – 4 milligrams Dexamethasone in 100mL normal saline given after spinal, over 5 minutes.
Intervention2: Group P: Group P – 1 gram Paracetamol in 100mL normal saline giv
Sponsors
SELF
Eligibility
Inclusion criteria
Inclusion criteria: 1.All patients posted for Trans Urethral Resection of Prostate procedure. 2.The patients who belong to American Society of Anesthesia 1, 2 and 3 physical statuses.
Exclusion criteria
Exclusion criteria: 1.Patients with spinal deformity. 2.Patients with allergic history to the drugs used in this study. 3.Any contraindication to subarachnoid block.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Incidence of shivering 2.Severity of shivering 3.Time to first onset of shivering 4.Total consumption of anti-shivering medication (IV Pethidine) Timepoint: TIME POINT A: Pre operative value during pre anaesthetic evaluation TIME POINT B : Prior to spinal anaesthesia TIME POINT C : Intra operatively for every 5 minutes upto 30 minutes from onset of spinal anaesthesia TIMEPOINT D : For every 30 minutes upto 180 minutes frm he onset of spinal anaesthesia in he post operative period | — |
Secondary
| Measure | Time frame |
|---|---|
| • side effects such as nausea, vomiting (treated using Metoclopramide 10 mg IV) will be recorded & considered as secondary outcome & treated accordingly. • Any serious adverse events such as anaphylactic or cardiac arrest during monitoring would be managed immediately & reported to the ethics committee. Timepoint: Temperature & shivering will be monitored every 5 minutes for 30 minutes & every 30 minutes for 2 & half hours. | — |
Countries
India
Contacts
Public ContactRahul G Bhat
SDM College of Medical Sciences and Hospital
Outcome results
None listed